Literature DB >> 22870090

MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review).

Megumi Yanokura1, Kouji Banno, Yusuke Kobayashi, Iori Kisu, Arisa Ueki, Asuka Ono, Kennta Masuda, Hiroyuki Nomura, Akira Hirasawa, Nobuyuki Susumu, Daisuke Aoki.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs of approximately 22 base pairs that regulate the expression of genes by targeting messenger RNA with complementarity with the miRNA base sequence. Regulation of gene expression by miRNAs is crucial in cellular development and differentiation, and recent studies suggest a relationship between human diseases and the breakdown of gene silencing mechanisms induced by miRNA abnormalities. In particular, abnormal miRNA expression has been detected in various types of cancer and the target genes have been identified. These results indicate that miRNAs act in a manner equivalent to oncogenes or tumor suppressors. miRNAs may also serve as diagnostic biomarkers and therapeutic targets. In this review, we introduce the latest findings on miRNAs in human endometrial cancer, a common malignancy, and discuss the potential of miRNAs as biomarkers and targets for molecular therapy.

Entities:  

Year:  2010        PMID: 22870090      PMCID: PMC3412506          DOI: 10.3892/ol.2010.173

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  24 in total

1.  Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.

Authors:  Stephen S Myatt; Jun Wang; Lara J Monteiro; Mark Christian; Ka-Kei Ho; Luca Fusi; Roberto E Dina; Jan J Brosens; Sadaf Ghaem-Maghami; Eric W-F Lam
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

2.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

3.  Reduced expression of Dicer associated with poor prognosis in lung cancer patients.

Authors:  Yoko Karube; Hisaaki Tanaka; Hirotaka Osada; Shuta Tomida; Yoshio Tatematsu; Kiyoshi Yanagisawa; Yasushi Yatabe; Junichi Takamizawa; Shinichiro Miyoshi; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Sci       Date:  2005-02       Impact factor: 6.716

4.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.

Authors:  C Welch; Y Chen; R L Stallings
Journal:  Oncogene       Date:  2007-02-12       Impact factor: 9.867

6.  MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.

Authors:  Nuo Yang; Sippy Kaur; Stefano Volinia; Joel Greshock; Heini Lassus; Kosei Hasegawa; Shun Liang; Arto Leminen; Shan Deng; Lori Smith; Cameron N Johnstone; Xian-Ming Chen; Chang-Gong Liu; Qihong Huang; Dionyssios Katsaros; George Adrian Calin; Barbara L Weber; Ralf Bützow; Carlo M Croce; George Coukos; Lin Zhang
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

7.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

8.  MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.

Authors:  Todd Boren; Yin Xiong; Ardeshir Hakam; Robert Wenham; Sachin Apte; ZhengZheng Wei; Siddharth Kamath; Dung-Tsa Chen; Holly Dressman; Johnathan M Lancaster
Journal:  Gynecol Oncol       Date:  2008-05-21       Impact factor: 5.482

9.  Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas.

Authors:  Eri Hiroki; Jun-Ichi Akahira; Fumihiko Suzuki; Satoru Nagase; Kiyoshi Ito; Takashi Suzuki; Hironobu Sasano; Nobuo Yaegashi
Journal:  Cancer Sci       Date:  2009-10-08       Impact factor: 6.716

10.  Specificity, duplex degradation and subcellular localization of antagomirs.

Authors:  Jan Krützfeldt; Satoru Kuwajima; Ravi Braich; Kallanthottathil G Rajeev; John Pena; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

View more
  23 in total

1.  MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.

Authors:  Tiechao Jiang; Dongming Sui; Dong You; Songmei Yao; Lirong Zhang; Yingjian Wang; Jixue Zhao; Yaozhong Zhang
Journal:  Cell Cycle       Date:  2018-07-23       Impact factor: 4.534

2.  Extracellular vesicles from osteosarcoma cell lines contain miRNAs associated with cell adhesion and apoptosis.

Authors:  Sofía Jerez; Héctor Araya; Daniel Hevia; Carlos E Irarrázaval; Roman Thaler; Andre J van Wijnen; Mario Galindo
Journal:  Gene       Date:  2019-06-06       Impact factor: 3.688

Review 3.  Prognostic biomarkers in endometrial and ovarian carcinoma.

Authors:  Xavier Matias-Guiu; Ben Davidson
Journal:  Virchows Arch       Date:  2014-02-07       Impact factor: 4.064

4.  Expression of the miR-190 family is increased under DDT exposure in vivo and in vitro.

Authors:  Tatiana S Kalinina; Vladislav V Kononchuk; Vladimir Y Ovchinnikov; Mikhail D Chanyshev; Lyudmila F Gulyaeva
Journal:  Mol Biol Rep       Date:  2018-11-12       Impact factor: 2.316

5.  MicroRNA-184 inhibits cell proliferation and metastasis in human colorectal cancer by directly targeting IGF-1R.

Authors:  Guannan Wu; Jiayun Liu; Zhenfeng Wu; Xiaoyu Wu; Xuequan Yao
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

6.  miR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3.

Authors:  Yunyun Li; Zhongzu Zhang; Xiuxia Liu; Tingting Huang; Wenfeng He; Yang Shen; Xin Liu; Kui Hong; Qing Cao
Journal:  Mol Cell Biochem       Date:  2013-11-28       Impact factor: 3.396

Review 7.  MicroRNAs in endometrial cancer.

Authors:  Kouji Banno; Megumi Yanokura; Iori Kisu; Wataru Yamagami; Nobuyuki Susumu; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2013-02-05       Impact factor: 3.402

8.  Expression of miRNA-630 in bladder urothelial carcinoma and its clinical significance.

Authors:  Zhi-Yu Wang; Wei Zhang; Jin-Jian Yang; Dong-Kui Song; Jin-Xing Wei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

Review 9.  Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents--implications for cancer treatment and chemoprevention.

Authors:  Eugenia Yiannakopoulou
Journal:  Cell Oncol (Dordr)       Date:  2014-07-05       Impact factor: 6.730

10.  MiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy.

Authors:  Xiaomin Ran; Juan Yang; Chaoxia Liu; Ping Zhou; Linzhi Xiao; Keqiang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.